Real-World Evidence (RWE) & Health Data Insights

At Moai Consulting, we specialize in leveraging real-world data (RWD) to generate evidence that informs healthcare decisions. Our RWE services include:
✔ Epidemiological & cost-effectiveness studies to assess real-world treatment impact
✔ Budget impact & disease burden analyses for policy and funding decisions
✔ Risk-sharing agreements monitoring to optimize reimbursement models
✔ Advanced statistical & machine learning techniques to uncover actionable trends

We help integrate RWE frameworks into clinical practice, ensuring that stakeholders can confidently make evidence-based decisions to improve patient care.

Understanding the true impact of diseases is critical for resource allocation and public health decision-making. We conduct comprehensive disease burden analyses, assessing:

✔ Economic Impact – Direct and indirect healthcare costs, lost productivity, and budget impact for payers
✔ Social Burden – The effect of diseases on quality of life, caregivers, and overall societal well-being
✔ Clinical Impact – Disease progression, treatment effectiveness, and healthcare system burden

We work with regulators, payers, and pharmaceutical companies to prioritize interventions, optimize healthcare investments, and improve patient care strategies.